苯丙胺酸市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球苯丙胺酸市場預計將從 2025 年的 5.8554 億美元成長到 2031 年的 7.4604 億美元，複合年成長率為 4.12%。

苯丙胺酸是一種必需胺基酸，作為酪胺酸的前體，在憂鬱症，在動物營養領域，它被用於促進牲畜飼料中的蛋白質合成。因此，這些產業已穩固確立了自身作為持續市場需求核心驅動力的地位。

然而，供應鏈集中化和地緣政治依賴性為市場成長帶來了重大障礙，使相關人員面臨供應穩定性和價格波動風險。主要經濟體對特定製造地原料供應的嚴重依賴進一步加劇了這種脆弱性。例如，根據飼料教育與研究協會的報告，2024年，美國約62%的胺基酸生產需求將依賴中國。這種生產能力的集中給苯丙胺酸市場帶來了明顯的風險，因為主要生產地區的貿易中斷或監管變化可能立即導致供不應求。

市場促進因素

全球苯丙胺酸市場主要受全球對低熱量甜味劑阿斯巴甜需求激增的推動，因為這種氨基酸是阿斯巴甜生產的關鍵前驅物。在健康意識增強和糖課稅政策的推動下，飲料生產商正積極拓展其零糖產品線，從而提振了對高純度苯丙胺酸的工業需求。主要企業大力推廣無糖產品，清楚反映了這一趨勢。例如，可口可樂公司在2025年10月報告稱，其「零糖可口可樂」系列第三季度銷量成長了14%，凸顯了阿斯巴甜基產品在刺激上游原料消費方面發揮的重要作用。

同時，高品質動物飼料添加劑的日益普及也支撐了市場需求。其中，苯丙胺酸被用於最佳化蛋白質合成和提高飼料轉換率。隨著農業部門採用精準營養以最大限度地減少對環境的影響，在飼料中添加必需胺基酸已成為確保糧食安全的標準做法。根據Alltech預測，到2024年全球飼料產量將成長1.2%，到2025年5月將達到13.96億噸，為添加劑需求奠定了穩定的基礎。韓國經濟日報在2024年12月報道稱，CJ第一製糖生物事業部的年銷售額預計將超過4兆韓元，這反映了該行業的巨大規模，凸顯了動物營養氨基酸生產所創造的巨大經濟價值。

市場挑戰

サプライチェーンの集中と地政学的依存は、世界のフェニルアラニン市場の成長にとって大きな障害となっています。この脆弱性は、規制の変更から物流のボトルネックに至るまで、局地的な混乱が即座に世界の供不應求へと波及する「単一障害点」を生み出し、市場の拡大を阻んでいます。フェニルアラニンの生産は限られた地域に集中しているため、市場にはショックを吸収するために必要な製造の冗長性が欠けています。その結果、アスパルテームの原料としてこの化合物に依存する食品,飲料業界などの下流セクターは、予測不可能な調達サイクルと極端な価格変動に直面しており、企業は防御的な運営を余儀なくされ、原料の不安定さにより事業規模の拡大やイノベーションの能力が制限されています。

這種製造業壟斷程度使全球相關人員在庫存安全方面處於岌岌可危的境地。根據美國飼料工業協會（AFIA）預測，到2025年，中國將控制全球約77%的離胺酸和91%的蘇氨酸供應，這代表著整個氨基酸行業的系統性集中，與苯丙胺酸的情況類似。單一製造地的這種壓倒性主導地位意味著，全球價格結構往往受單一國家的政策決策所驅動，而非自然的供需機制。這種嚴重的依賴阻礙了國際買家的長期資本投資，他們將缺乏替代來源視為不可控制的商業風險，最終導致整體市場成長放緩。

市場趨勢

在製藥業，苯丙胺酸正日益成為新型胜肽藥物合成的關鍵成分，其作用已超越了傳統的添加劑角色。這一趨勢主要源於市場對肽類療法的爆炸性成長的需求，尤其是用於治療糖尿病和體重管理的GLP-1受體促效劑。這些藥物的療效依賴於精確的胺基酸序列。隨著這些複雜的生物製藥產品市場佔有率的擴大，用於胜肽合成的高純度苯丙胺酸需求也隨之激增，以支持上游藥物研發。 Neuland Labs在其2024年9月發布的關於胜肽類藥物發展趨勢的報導中指出，2023年減肥藥的臨床試驗數量成長了68%，顯示這一高價值領域對氨基酸的需求十分旺盛。

同時，製造商正從化學合成轉向先進的微生物發酵工藝，以提供更高的產量效率和永續性。這種轉變使生產者能夠擴大生產規模以滿足全球需求，同時減少傳統石化方法對環境的影響。業內公司正大力投資建造新的基礎設施以支持這種生物基生產模式，透過垂直整合確保原料供應並降低成本。例如，根據國際文傳電訊社2024年11月報道，阜豐集團計畫投資高達3.5億美元，在哈薩克建立一個垂直整合的產業園區，用於玉米加工和胺基酸生物發酵。這顯示大量資金正湧入，用於提升製造能力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球苯丙胺酸市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（L-苯丙胺酸、D-苯丙胺酸、DL-苯丙胺酸）
  • 依應用領域（憂鬱症、注意力不足症、巴金森氏症、慢性疼痛、白斑症等）
  • 按最終使用者（食品和飲料、營養補充品、藥品、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美苯丙胺酸市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲苯丙胺酸市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區苯丙胺酸市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲苯丙胺酸市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美苯丙胺酸市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球苯丙胺酸市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Ajinomoto Co., Inc.
• DAESANG
• Livzon
• KYOWA HAKKO BIO CO., LTD
• Amazing Nutrition
• AMINO GmbH
• Wuxi Jinghai Amino Acid Co., Ltd
• Shijiazhuang Jirong Pharmaceutical Co., Ltd
• Shijiazhuang Haitian Amino Acid Co., Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Phenylalanine Market is projected to expand from USD 585.54 Million in 2025 to USD 746.04 Million by 2031, registering a CAGR of 4.12%. Phenylalanine serves as an essential amino acid and a precursor to tyrosine, playing a vital role in the biosynthesis of neurotransmitters such as dopamine and norepinephrine. The market is primarily propelled by strong demand for the artificial sweetener aspartame, a key ingredient in low-calorie food and beverage items. Furthermore, the pharmaceutical industry utilizes the compound to treat conditions like depression and vitiligo, while the animal nutrition sector employs it to enhance protein synthesis in livestock feed, solidifying these industries as the core drivers of sustained market demand.

However, market growth encounters significant hurdles due to supply chain concentration and geopolitical dependency, which expose stakeholders to risks regarding availability and pricing volatility. This vulnerability is intensified by the heavy reliance of major economies on specific manufacturing hubs for raw materials. For instance, the Institute for Feed Education and Research reported that in 2024, the United States depended on China for roughly 62% of its amino acid production needs. Such centralized manufacturing capacity creates distinct risks for the phenylalanine market, as trade disruptions or regulatory changes in the dominant production region could trigger immediate supply shortages.

Market Driver

The Global Phenylalanine Market is significantly driven by the surging global demand for low-calorie aspartame sweeteners, as this amino acid acts as a primary precursor for aspartame production. Driven by increasing health awareness and sugar taxation policies, beverage manufacturers are aggressively expanding their zero-sugar portfolios, thereby boosting the industrial requirement for high-purity phenylalanine. This trend is evident in the strong uptake of sugar-free offerings by major players; for example, The Coca-Cola Company reported in October 2025 that its Coca-Cola Zero Sugar line achieved a 14% volume increase during the third quarter, highlighting the critical role of aspartame-based formulations in stimulating upstream ingredient consumption.

Simultaneously, the market is supported by the growing adoption of high-quality animal feed additives, where phenylalanine is utilized to optimize protein synthesis and improve feed conversion ratios. As the agricultural sector adopts precision nutrition to minimize environmental impact, including essential amino acids in feed has become standard practice for ensuring food security. According to Alltech, global feed production rose by 1.2% in 2024 to reach 1.396 billion metric tons by May 2025, establishing a stable foundation for additive demand. Reflecting the sector's massive scale, The Korea Economic Daily noted in December 2024 that CJ CheilJedang's bio division was expected to exceed 4 trillion won in annual revenue, underscoring the substantial economic value generated by amino acid production for animal nutrition.

Market Challenge

The concentration of supply chains and geopolitical dependency presents a formidable obstacle to the growth of the Global Phenylalanine Market. This vulnerability impedes expansion by creating a single point of failure where localized disruptions-ranging from regulatory shifts to logistical bottlenecks-can cascade into immediate global shortages. Since phenylalanine production is heavily consolidated within limited geographic regions, the market lacks the manufacturing redundancy required to absorb shocks. Consequently, downstream sectors such as the food and beverage industry, which rely on the compound for aspartame, face unpredictable procurement cycles and extreme pricing volatility, forcing companies to operate defensively and limiting their ability to scale or innovate due to raw material insecurity.

The extent of this manufacturing monopolization places global stakeholders in a precarious position regarding inventory security. According to the American Feed Industry Association, in 2025, China controlled approximately 77% of the global supply for lysine and 91% for threonine, indicating a systemic centralization across the amino acid sector that mirrors the landscape for phenylalanine. This overwhelming dominance by a single manufacturing hub means that global pricing structures are often dictated by one nation's policy decisions rather than organic supply and demand mechanics. Such profound dependency discourages long-term capital investment from international buyers who view the lack of alternative supply sources as an unmanageable operational risk, thereby stifling overall market growth.

Market Trends

The pharmaceutical sector is increasingly utilizing phenylalanine as a critical building block for synthesizing novel peptide drugs, moving beyond its traditional role as a simple excipient. This trend is largely fueled by the explosive demand for peptide-based therapeutics, particularly GLP-1 receptor agonists used in diabetes care and weight management, which rely on precise amino acid sequences for efficacy. As these complex biologics capture more market share, the need for high-purity phenylalanine for peptide synthesis has surged to support upstream drug development. Neuland Labs noted in a September 2024 article on peptide trends that clinical trials for obesity drugs increased by 68% in 2023, signaling a robust trajectory for amino acid consumption in this high-value segment.

Concurrently, manufacturers are shifting from chemical synthesis to advanced microbial fermentation processes, which offer higher yield efficiency and improved sustainability profiles. This transition allows producers to mitigate the environmental impact of traditional petrochemical methods while scaling operations to meet global needs. Industry players are investing heavily in new infrastructure to support this bio-based production model, securing raw material access and reducing costs through vertical integration. For instance, Interfax reported in November 2024 that Fufeng Group plans to invest up to USD 350 million to establish a vertically integrated industrial park in Kazakhstan for corn processing and amino acid bio-fermentation, highlighting the significant capital flow into modernizing manufacturing capabilities.

Key Market Players

• Ajinomoto Co., Inc.
• DAESANG
• Livzon
• KYOWA HAKKO BIO CO., LTD
• Amazing Nutrition
• AMINO GmbH
• Wuxi Jinghai Amino Acid Co., Ltd
• Shijiazhuang Jirong Pharmaceutical Co., Ltd
• Shijiazhuang Haitian Amino Acid Co., Ltd

Report Scope

In this report, the Global Phenylalanine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phenylalanine Market, By Type

• L-Phenylalanine
• D-Phenylalanine
• DL-Phenylalanine

Phenylalanine Market, By Application

• Depression
• Attention Deficit Disorder
• Parkinson disease
• Chronic Pain
• Vitiligo
• Others

Phenylalanine Market, By End-Users

• Food and Beverage
• Dietary Supplements
• Pharmaceuticals
• Others

Phenylalanine Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phenylalanine Market.

Available Customizations:

Global Phenylalanine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Phenylalanine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (L-Phenylalanine, D-Phenylalanine, DL-Phenylalanine)
  • 5.2.2. By Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic Pain, Vitiligo, Others)
  • 5.2.3. By End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Phenylalanine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End-Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Phenylalanine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Users
  • 6.3.2. Canada Phenylalanine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Users
  • 6.3.3. Mexico Phenylalanine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Users

7. Europe Phenylalanine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End-Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Phenylalanine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Users
  • 7.3.2. France Phenylalanine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Users
  • 7.3.3. United Kingdom Phenylalanine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Users
  • 7.3.4. Italy Phenylalanine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Users
  • 7.3.5. Spain Phenylalanine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Users

8. Asia Pacific Phenylalanine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Phenylalanine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Users
  • 8.3.2. India Phenylalanine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Users
  • 8.3.3. Japan Phenylalanine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Users
  • 8.3.4. South Korea Phenylalanine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Users
  • 8.3.5. Australia Phenylalanine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Users

9. Middle East & Africa Phenylalanine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End-Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Phenylalanine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Users
  • 9.3.2. UAE Phenylalanine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Users
  • 9.3.3. South Africa Phenylalanine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Users

10. South America Phenylalanine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End-Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Phenylalanine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Users
  • 10.3.2. Colombia Phenylalanine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Users
  • 10.3.3. Argentina Phenylalanine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Phenylalanine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ajinomoto Co., Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. DAESANG
• 15.3. Livzon
• 15.4. KYOWA HAKKO BIO CO., LTD
• 15.5. Amazing Nutrition
• 15.6. AMINO GmbH
• 15.7. Wuxi Jinghai Amino Acid Co., Ltd
• 15.8. Shijiazhuang Jirong Pharmaceutical Co., Ltd
• 15.9. Shijiazhuang Haitian Amino Acid Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer